nivolumab in combination with ipilimumab (Opdivo® in combination with Yervoy®)
Application Details
HSE100097
26011
nivolumab in combination with ipilimumab
Opdivo® in combination with Yervoy®
Bristol Myers Squibb
19/03/2026
28/02/2025
Application Status
Proposal from Applicant Under Review
24/06/2026
Awaiting Proposal from Applicant
10/06/2026
Applicant Meeting Held with CPU
10/06/2026
Rapid Review Completed
16/04/2026
Pricing and Reimbursement Application Complete
19/03/2026
Rapid Review Commissioned
12/03/2026